총 2,820건 중 1,000건 출력
, 36/100 페이지
-
351
-
Establishing Acceptance Limits for Dissolution Performance Verification of USP Apparatus 1 and 2 Using USP Prednisone Tablets Reference Standard Lot Q0H398
-
Hauck, W.W.;
Li, C.;
Stippler, E.S.;
Brown, W.E.;
;
(Dissolution technologies,
v.20,
2013,
pp.6-12)
-
352
-
Interaction of Flavin Adenine Dinucleotide (FAD) with a Glassy Carbon Electrode Surface
-
Wei, Haizhen;
Omanovic, Sasha;
Department of Chemical Engineering, McGill University Montreal, 3610 University Street, Montreal Quebec, H3A 2B2, Canada, (phone: +1 (514) 398‐
4273;
fax: +1 (514) 398‐
6678);
Department of Chemical Engineering, McGill University Montreal, 3610 University Street, Montreal Quebec, H3A 2B2, Canada, (phone: +1 (514) 398‐
4273;
fax: +1 (514) 398‐
6678);
(Chemistry & biodiversity,
v.5,
2008,
pp.1622-1639)
-
353
-
Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor
-
Yamamoto, T.;
Nozaki-Taguchi, N.;
;
(Brain research,
v.739,
1996,
pp.104-110)
-
354
-
813. Instrumental method for high-vacuum handling : <B>J M Guerrero and G Rodriguez,</B><I>J Vac Sci Technol</I>, <B>10</B> (2), <I>March–April</I> 1973, 398–400.
-
;
;
(Vacuum,
v.23,
1973,
pp.428-428)
-
355
-
Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures
-
Kä
hkö
nen, T. E.;
Toriseva, M.;
Petruk, N.;
Virta, A.-R.;
Maher, A.;
Eigé
liené
, N.;
Kaivola, J.;
Boströ
m, P.;
Koskivuo, I.;
Nees, M.;
Tuomela, J. M.;
Ivaska, K. K.;
Hä
rkö
nen, P. L.;
University of Turku, Institute of Biomedicine, 20520 Turku, Finland;
University of Turku, Institute of Biomedicine, 20520 Turku, Finland;
University of Turku, Institute of Biomedicine, 20520 Turku, Finland;
University of Turku, Institute of Biomedicine, 20520 Turku, Finland;
University of Turku, Institute of Biomedicine, 20520 Turku, Finland;
University of Turku, Institute of Biomedicine, 20520 Turku, Finland;
University of Turku, Institute of Biomedicine, 20520 Turku, Finland;
Department of Pathology, Turku University Hospital, 20520 Turku, Finland;
Department of Plastic and General Surgery, Turku University Hospital, 20520 Turku, Finland;
University of Turku, Institute of Biomedicine, 20520 Turku, Finland;
University of Turku, Institute of Biomedicine, 20520 Turku, Finland;
University of Turku, Institute of Biomedicine, 20520 Turku, Finland;
University of Turku, Institute of Biomedicine, 20520 Turku, Finland;
(Cellular oncology,
v.44,
2021,
pp.205-218)
-
356
-
Abstract LB-092: TAS120, a covalently-binding FGFR inhibitor (FGFRi), overcomes resistance to BGJ398 in patients with FGFR2 fusion positive cholangiocarcinoma
-
Goyal, Lipika;
Liu, Leah Y.;
Lennerz, Jochen K.;
Harding, James J.;
Huang, Jerry;
Winkler, Robert;
Hiroshi, Hirai;
Ting, David T.;
Juric, Dejan;
Corcoran, Ryan B.;
El-Bardeesy, Nabeel;
Zhu, Andrew X.;
;
(Cancer research : the official organ of the American Association for Cancer Research, Inc,
v.78,
2018,
pp.LB-092-LB-092)
-
357
-
Experimental (ρ,P,T) data of H2 + CH4 mixtures at temperatures from 278 to 398 K and pressures up to 56 MPa
-
Owuna, Friday Junior;
Chapoy, Antonin;
Ahmadi, Pezhman;
Burgass, Rod;
;
(International journal of hydrogen energy,
v.68,
2024,
pp.979-997)
-
358
-
Prediction of vapour - liquid equilibrium for the binary mixture acetic acid (1) + diethyl ether (2) at temperature 348.15 K and 398.15 K
-
Van Tat, P.;
;
(Tap chí hóa hoc = Vietnam journal of chemistry,
v.46,
2008,
pp.554-559)
-
359
-
Effects of the selective cyclo-oxygenase-2 inhibitor NS398 on prostanoid release from the stomach and other rat organs: comparison with non-selective COX-inhibitors
-
Tegeder, I.;
Neupert, W.;
Guehring, H.;
Brune, K.;
;
(British Pharmacological Society,
v.1999,
1999,
pp.99P)
-
360
-
Contribution of Vasoactive Eicosanoids and Nitric Oxide Production to the Effect of Selective Cyclooxygenase-2 Inhibitor, NS-398, on Endotoxin-Induced Hypotension in Rats
-
Tunctan, Bahar;
Korkmaz, Belma;
Cuez, Tuba;
Kemal Buharalioglu, C.;
Sahan-Firat, Seyhan;
Falck, John;
Malik, Kafait U.;
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey;
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey;
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey;
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey;
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey;
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USA;
Department of Pharmacology, College of Medicine, The University of Tennessee, Center for Health Sciences, Memphis, TN, USA;
(Basic & clinical pharmacology & toxicology,
v.107,
2010,
pp.877-882)